Skip to content

Symptoms and Outcome Measures for Upper- Limb Function in Myotonic Dystrophy Type 1

Symptoms and Outcome Measures for Upper- Limb Function in Myotonic Dystrophy Type 1

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05006924
Acronym
SOUL-DM1
Enrollment
89
Registered
2021-08-16
Start date
2021-12-10
Completion date
2024-08-31
Last updated
2025-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myotonic Dystrophy 1

Keywords

Outcome measure, Patient reported outcome, Upper limb function, arm- and hand function, Symptoms

Brief summary

Myotonic Dystrophy type 1 (DM1) is a multisystem disease that causes muscle weakness and myotonia. As a result upper limb function might become impaired. In this study we will examine patients with DM1 and record their upper limb function. We will will use a battery of patient reported outcomes (PROs) and Outcome measures (OMs) in order to evalute which ones are suitable for use in clinical practise and research studies.

Interventions

None listed

Sponsors

University of Oslo
CollaboratorOTHER
Haukeland University Hospital
CollaboratorOTHER
Oslo University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

• Genetically confirmed Myotonic Dystrophy type 1

Exclusion criteria

* Unable to answer or understand questionnaires due to language barriers or cognitive status * Unable to perform functional tests

Design outcomes

Primary

MeasureTime frameDescription
ACTIVLIM Questionnaire5 minA measure of activity limitations for patients with upper and/or lower limb impairments. The scale measures a patient's ability to perform daily activities requiring the use of the upper and/or the lower limbs, whatever the strategies involved. Consists of 22 questions (18 to be answered by adults). The categories are easy, difficult or unable to perform. The questionnaire gives a sum score where higher score equals better function. Score fror 0 to 36
Motor Function Measures (MFM)30-45 minutesFunctional test
Nine Hole Peg Test1-3 minutesFine motor function test
Myogrip/Dynamometer1-3 minutesMeasures hand strenght
Myopinch1-3 minutesMeasures finger strenght
ABILHAND Questionnaire5 minA measure of manual ability for adults with upper limb impairments. The scale measures a person's ability to manage daily activities that require the use of the upper limbs, whatever the strategies involved. Consists of 22 questions (18 to be answered by adults). The categories are easy, difficult or unable to perform. The querionnaire gives a sum score where higher score equals better function.Score from 0 to 36

Secondary

MeasureTime frameDescription
Trunk Impairment Scale - modified Norwegian version8-15 minutesMotor impairment of trunk measured by functional testing. Six subdomains measuring stability and mobility of trunkal movement. Min score 0 - Max score 16. Higher score indicates better function.
Four Square Step Test1-3 minutesDynamic balance test
PROMIS295-10 minutesThis a compostie measurement that is a Questionnaire. Patient reported outcome measure. Generic health related quality of life assesses each of the 7 PROMIS domains (depresseion, anxiety, physical function, pain, fatigue, sleep disturbance and ability to participate in social roles). The PROMIS 29 questionnaire contains 4 questions from each of seven PROMIS contents (physical function, depression, anxiety, fatigue, sleep disorder, participation in social activities and pain interaction) and 1 question from the intensity of pain. Each item has 5 answer options (from 1 to 5), only pain intensity has 11 answer options (from 0 to 10). From the sum of the answers to each question in the domain, the total raw score for each domain is calculated, resulting in seven domain scores, each between 4 and 20.
Starkstein Apathy Scale5 minutesQuestionnaire to be filled in under guidance of interviewer. Patient reported outcome measure of apathy. 14 questions, each of which is scored on a 4-point scale of 0-3, and apathy is rated as severer as the total score (0-42) increases
Montreal Cognitive Assessment (MoCA)10 minutesCognitive assessment screening questionnaire. To be filled out in an interview setting. Score from 0 to 30, where a higher score indicates a better cognitive function. A score of 26 or more is considered normal.
Lung function test10 minutesSpirometry with FVC (Forced Vital Capasity)

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026